Clinical trials
Observational Leukemia, Hairy Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 3 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 9 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 3 |
| Vanderbilt-Ingram Cancer Center | 3 |
| Case Comprehensive Cancer Center | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Vanderbilt University | 2 |
| AstraZeneca | 1 |
| Children's Oncology Group | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Mayo Clinic | 1 |
| Mustang Bio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Hairy Cell | 23 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 21 |
| Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 19 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 19 |
| Blast Crisis | 18 |
| Leukemia, Myeloid, Accelerated Phase | 18 |
| Congenital Abnormalities | 17 |
| Leukemia, Myeloid, Acute | 17 |
| Leukemia, Myeloid, Chronic-Phase | 17 |
| Leukemia, Myelomonocytic, Chronic | 17 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.